U.S. Physical Therapy, Inc. Financials

Market Capitalization $1.20 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	33.28
Forward PE	26.34
Price to Sales TTM	$1.60
Price to Book MRQ	$2.38
Enterprise to Revenue	2.34
Enterprise to EBITDA	17.66

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-09-30
Profit Margin	5.95%
Operating Margin	9.95%
Return on Assets TTM	4.26%
Return on Equity TTM	8.44%

Income Statement

Revenue TTM	$750,947,968
Revenue per Share TTM	$49.55
Quarterly Revenue Growth	17.30%
Gross Profit TTM	$164,906,000
EBITDA	$101,073,000
Net Income to Common TTM	$36,017,000
Diluted EPS TTM	$2.37
Quarterly Earnings Growth YoY	98.20%

Balance Sheet

Total Cash MRQ	$32,110,000
Total Cash per Share MRQ	$2.11
Total Debt MRQ	$
Total Debt to Equity MRQ	39.42
Current Ratio MRQ	1.20
Book Value per Share MRQ	$33.12

Cash Flow

Operating Cash Flow TTM	$69,535,000
Levered Free Cash Flow TTM	$34,739,876

USPH Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	15,204,119
Float Shares	14,890,306
Avg 10 Volume	142,230
Avg 30 Volume	None
Shares Short	764,911
Short Ratio	3.85
Short % of Shares	6.00%
% Held by Insiders	1.94%
% Held by Institutions	107.83%

Stock Price Summary

Beta	1.32
Fifty Two Week Low	$62.77
Fifty Two Week High	$93.50
Fifty Two Week Change	-12.22%
Day 50 MA	$78.92
Day 200 MA	$78.14

Dividends and Splits

Forward Annual Dividend Rate	$1.80
Forward Annual Dividend Yield	2.28%
Trailing Annual Dividend Rate	$1.80
Trailing Annual Dividend Yield	2.28%
Payout Ratio	75.53%
Dividend Date	2025-12-12
Ex Dividend Date	2025-11-17
Last Split Factor
Last Split Date	2001-06-29